Fibrin Nanoparticles as a Promising Anti-cancer Activity on MCF-7 Cells

AuthorNahid Moradi Gharibvanden
AuthorBatool Hashemi Benien
OrcidBatool Hashemi Beni [0000-0001-9656-2355]en
Issued Date2024-01-31en
AbstractBackground: Drug delivery methods based on nanoparticles have shown promise in the treatment of cancer. The nanoparticles (NPs) have a cytotoxicity effect on cancer cells. Objectives: This study aimed to evaluate the effect of fibrin nanoparticles (FNPs) on breast cancer cells. Methods: MCF-7 cell lines were treated with 100 µg/mL of FNP for 5 days. On day five, gene and protein expression were evaluated to determine the anti-cancer effects of the FNPs. Results: BCL2, an anti-apoptotic (BCL2) and angiogenic (VEGF) genes and proteins were downregulated in the FNP treatment in comparison with control cells. Conclusions: The study's findings indicate that FNPs considerably reduce anti-apoptotic and angiogenic gene expression in human breast cancer cells.en
DOIhttps://doi.org/10.5812/chbs-154439en
URIhttps://brieflands.com/journals/chbs/articles/154439en
KeywordFibrin Nanoparticlesen
KeywordMCF-7en
KeywordAnti-activityen
PublisherBrieflandsen
TitleFibrin Nanoparticles as a Promising Anti-cancer Activity on MCF-7 Cellsen
TypeResearch Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
chbs-2-3-154439-publish-pdf.pdf
Size:
1018.29 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF